At a Glance
| Semax | Methylene Blue | |
|---|---|---|
| Class | Nootropic, Neuroprotective | Nootropic, Neuroprotective, Mitochondrial enhancer |
| Routes | Intranasal | Oral |
| Effects | 0 documented | 9 documented |
Semax, a Nootropic, Neuroprotective, and Methylene Blue, a Nootropic, Neuroprotective, Mitochondrial enhancer, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Semax is classified as a Nootropic, Neuroprotective while Methylene Blue is a Nootropic, Neuroprotective, Mitochondrial enhancer, meaning they approach altered states through different pharmacological mechanisms. They share 0 documented effects in common, with 0 effects unique to Semax and 9 unique to Methylene Blue. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Semax | Methylene Blue | |
|---|---|---|
| Class | Nootropic, Neuroprotective | Nootropic, Neuroprotective, Mitochondrial enhancer |
| Routes | Intranasal | Oral |
| Effects | 0 documented | 9 documented |
| Level | Dose |
|---|
| Threshold | 50 mcg |
| Light | 100–200 mcg |
| Common | 200–600 mcg |
| Strong | 600–900 mcg |
| Heavy | 1200 mcg |
| Level | Dose |
|---|---|
| Threshold | 5 mg |
| Light | 5–15 mg |
| Common | 15–50 mg |
| Strong | 50–100 mg |
| Heavy | 200 mg |
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.